Medline MDLN
NASDAQ MDLN
$34.70 -0.28 (-0.80%)
At close: Sep 30, 2026 · 4:00 PM EDT

Medline (MDLN) EBITDA Margin (2025 - 2026)

Updated

Medline's EBITDA Margin came in at 8.47% for Q2 2026, down 4.48 percentage points from 12.95% a year earlier and down 0.72 percentage points from the prior quarter.

Analysis

Medline (MDLN) EBITDA Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 27, 2026, Medline reported EBITDA Margin of 10.63%; for FY2025, it came in at 11.34%, down 0.91 percentage points from FY2024.

  • Going back by year, EBITDA Margin was 12.24% in FY2024 (+2.77 pp) and 9.47% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 21.86%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 41.08%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 25.55%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 28.17%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 31.93%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 24.62%
10 Medline 45.62 Bn 46.07 Bn 2.22 Bn 8.47%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 8.47%
Mar 28, 2026 9.19%
Jun 28, 2025 12.95%
Mar 29, 2025 12.31%
API Access

Medline EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MDLN&period=max&api_key=YOUR_API_KEY